Associated Papers
De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.
Xu D et al.
Embo Molecular Medicine, 2025
40707702 (PubMed )
Supplement: 44321_2025_278_MOESM15_ESM.xlsx › Sheet1
Select a paper to view details